SCHEMBL29371808

SCHEMBL29371808

CNS(=O)(=O)c1ccc(-c2cccc3cnc(Nc4cccc(N5CCN(C)CC5)c4)nc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 13/20 0.58
▸ BRD4 O60885 4/20 0.58
▸ JAK3 P52333 10/20 0.56
▸ PTK2 Q05397 9/20 0.56
▸ JAK1 P23458 2/20 0.56
▸ ABCB1 P08183 1/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ FGFR1 P11362 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ CCNT1 O60563 1/20 0.49
▸ CCNA2 P20248 1/20 0.49
▸ CDK2 P24941 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ HTR1A P08908 1/20 0.48
▸ HTR2A P28223 1/20 0.48
▸ HTR2C P28335 1/20 0.48
▸ HTR7 P34969 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ HTR6 P50406 1/20 0.48
▸ EGFR P00533 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18377030 1.00 JAK2 (0.58) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18377076 0.91 JAK2 (0.65) JAK2BRD4JAK3PTK2JAK1
SCHEMBL28696326 0.91 JAK2 (0.67) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376753 0.91 PTK2 (0.56) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376247 0.91 BRD4 (0.60) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376846 0.90 JAK2 (0.56) JAK2BRD4JAK3PTK2CYP3A4
SCHEMBL18376835 0.90 EGFR (0.58) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376740 0.89 JAK2 (0.57) JAK2BRD4JAK3PTK2JAK1
SCHEMBL30859687 0.89 JAK2 (0.57) JAK2BRD4JAK3PTK2JAK1
SCHEMBL18376739 0.88 JAK2 (0.54) JAK2BRD4JAK3PTK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
Send feedback